About us
OPTOPOL Technology is a Polish company with a global reach that has been shaping the future of ophthalmic diagnostics for over 30 years. As pioneers in spectral domain OCT, we were the first in the world to commercialize this breakthrough technology — transforming the way retinal and optic nerve diseases are diagnosed.
We support ophthalmologists, optometrists, and eye surgeons around the world in their daily work by delivering diagnostic devices that are precise, fast, and intuitive to use.
Innovation Serving Ophthalmology
Our flagship device, the REVO HR, is the outcome of years of research and development. It combines high-resolution imaging, automated measurements, and advanced data analysis, enabling early detection of pathological changes and efficient treatment monitoring. As a result, doctors gain not only a better view of the eye – but also greater diagnostic confidence.
Global Reach
OPTOPOL products are used in hundreds of clinics, hospitals, and eye care practices around the world. Alternatywa: Every day, thousands of OPTOPOL devices assist ophthalmologists in clinics, hospitals and eye care practices around the world. We participate in major industry congresses, collaborate with a global community of specialists, and closely listen to the needs of physicians.
Why OPTOPOL Technology?
- Experience and a pioneering approach
- World-class spectral domain OCT technology
- A team of experts passionate about ophthalmology
- In-house R&D and manufacturing in Poland
- Technical and content support for customers worldwide
Join the community of professionals who choose reliability, innovation, and quality – choose Optopol Technology.
30+ Years of Innovation
OPTOPOL Technologies was founded by the late Adam Bogdani in 1992 and is now run by his son, Marcin Bogdani. Based approximately 70 kilometers north of Kraków, Poland, OPTOPOL now has several R&D locations and a U.S. subsidiary. OPTOPOL has become one of the world leaders in automated perimetry and spectral domain OCT with thousands of devices in use in over 90 countries.
30+ Years of Innovation
OPTOPOL Technology's Timeline
1992
Registration of OPTOPOL Sp. z o.o. (Limited).
1999
Establishment of OPTOPOL Sp. z o.o. (OPTOPOL Sp. z o.o. took over 100% of shares). Beginning of production of own medical devices.
2002
OPTOPOL Sp. z o.o. obtains ISO 9001:2000 certificate for design, production and sales of medical devices, issued by Det Norske Veritas, Norway.
2004
OPTOPOL Sp. z o.o. obtains ISO 13485:2003 certificate.
2005
SOCT Copernicus: the world's first spectral OCT
2005
OPTOPOL Sp. z o.o. extends activities to export sales.
2005
Registration of OPTOPOL S.A. (Joint-Stock Company).
2006
Start of series production of Spectral Optical Coherence Tomography SOCT Copernicus.
2006
OPTOPOL Sp. z o.o. changes its name into OPTOPOL Technology Sp. z o.o.
2006
First participation in American Academy of Ophthalmology.
2007
Second participation in American Academy of Ophthalmology. First presentation of SOCT Copernicus HR – Milestone in Spectral Tomography. First presentation of SOCT Anterius – first device in spectral technology for anterior segment of human eye.
2008
OPTOPOL Technology S.A. makes its debut on the Warsaw Stock Exchange.
2010
OPTOPOL Technology S.A. joins the Canon Group.
2014
OPTOPOL leaves the Canon Group and continues to develop diagnostic devices for ophthalmology as an independent company.
2015
The new SOCT Copernicus REVO was presented at the ESCRS Congress in Barcelona.
2015
The Automated Perimeter PTS-920 was launched.
2016
The Automated Perimeter PTS-925 was launched.
2016
During ESCRS Congress in Copenhagen OPTOPOL Technology presented the fastest OCT on the market.
2017
The fastest OCT on the market REVO NX and Automated Perimeter PTS-2000 were launched.
2020
Establishment of US Subsidiary.
2021
Release of REVO FC 130 OCT | Fundus Camera.
2024
Launch of the REVO HR and Ultra-Widefield Module.